220 related articles for article (PubMed ID: 32441006)
1. Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission.
Araujo-Castro M; Pascual-Corrales E; Martínez-Vaello V; Baonza Saiz G; Quiñones de Silva J; Acitores Cancela A; García Cano AM; Rodríguez Berrocal V
J Endocrinol Invest; 2021 Jan; 44(1):183-193. PubMed ID: 32441006
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.
Jane JA; Starke RM; Elzoghby MA; Reames DL; Payne SC; Thorner MO; Marshall JC; Laws ER; Vance ML
J Clin Endocrinol Metab; 2011 Sep; 96(9):2732-40. PubMed ID: 21715544
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA
J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C; Oearsakul T
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[TBL] [Abstract][Full Text] [Related]
8. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
10. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.
Zhang S; Chen J; Yao S; Akter F; Wang Z; Hu B; Zhu D; Duan C; Chen W; Zhu Y; Wang H; Mao Z
J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731
[TBL] [Abstract][Full Text] [Related]
11. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
12. Predictors of surgical outcome and early criteria of remission in acromegaly.
Antunes X; Ventura N; Camilo GB; Wildemberg LE; Guasti A; Pereira PJM; Camacho AHS; Chimelli L; Niemeyer P; Gadelha MR; Kasuki L
Endocrine; 2018 Jun; 60(3):415-422. PubMed ID: 29626274
[TBL] [Abstract][Full Text] [Related]
13. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
14. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study.
Shen M; Shou X; Wang Y; Zhang Z; Wu J; Mao Y; Li S; Zhao Y
Endocr J; 2010; 57(12):1035-44. PubMed ID: 21099129
[TBL] [Abstract][Full Text] [Related]
15. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
[TBL] [Abstract][Full Text] [Related]
16. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S; Jacob KS; Pratheesh R; Chacko AG
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[TBL] [Abstract][Full Text] [Related]
17. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly.
Aydin S; Ozoner B; Sahin S; Alizada O; Comunoglu N; Oz B; Gazioglu N; Kadioglu P; Tanriover N
Clin Neurol Neurosurg; 2020 Nov; 198():106201. PubMed ID: 32927330
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic endonasal approach for acromegaly: surgical outcomes using 2018 consensus criteria for remission.
de Carvalho Cavalcante RA; Vieira LA; Peres LFA; Zaccariotti AJ; de Sousa Alencar H; Jatene EM; Camargo LA; Dias Rodrigues ML
Arch Endocrinol Metab; 2023 Jun; 67(6):e000650. PubMed ID: 37364152
[TBL] [Abstract][Full Text] [Related]
19. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature.
Minniti G; Jaffrain-Rea ML; Esposito V; Santoro A; Tamburrano G; Cantore G
Endocr Relat Cancer; 2003 Dec; 10(4):611-9. PubMed ID: 14713271
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
